Enzalutamide-induced severe thrombocytopenia complicated by a seizure in a 76-year-old man with castration-resistant prostate cancer.

Masaki MurataItsuhiro TakizawaRyo MaruyamaTakashi KasaharaNoboru HaraYoshihiko Tomita

Published in: IJU case reports (2018)

Thrombocytopenia may occur early following enzalutamide therapy, and blood analysis within 2 weeks after treatment may facilitate its management. Enzalutamide-induced thrombocytopenia, complicated by seizure, has not been reported.

Keyphrases

prostate cancer
high glucose
diabetic rats
drug induced
early onset
oxidative stress
cell therapy